AOiA Leads Digital Health Innovation at OMED24
Join AOiA’s Digital Health Innovation Hub at OMED24, where experts will explore the future of osteopathic medicine through AI, digital health policy, education.
Johnson & Johnson’s RYBREVANT® Shows Promising Results in Lung Cancer Study
RYBREVANT®Johnson’s with chemotherapy shows improved survival outcomes for EGFR-mutated NSCLC patients in Johnson & Johnson’s Phase 3 MARIPOSA-2 study.
Rising EEE Cases In The Northeast: How Homeowners Can Protect
Protect your family from rising Eastern Equine Encephalitis (EEE) cases with expert tips on mosquito prevention. Stay informed on effective safety measures.
America’s Falling Birthrate: A Baby Bust in the Making?
America’s declining birthrate has become a vital issue in the 2024 election, with both parties offering policies to boost family growth and economic stability.
Study Links Air Pollution to Increased Liver Disease
A new study reveals that long-term exposure to air pollution and unhealthy lifestyle choices significantly increase the risk of developing NAFLD.
Grit Biotechnology Secures FDA Approval For Cancer Therapy
Grit Biotechnology secures FDA approval for GT201, a cutting-edge cancer therapy advancing clinical trials in the U.S. and China.